News
Wondering how to feel about Ozempic? These unexpected questions help reveal what may really be driving your reaction and how ...
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Now, favouring a wholesome life by the sea, the TV presenter turned author, 67, spends her days writing novels and working ...
With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...
Two companion papers out of Rutgers University — published June 14 in Nature Metabolism and Nature Communications—have traced ...
4hOpinion
The Hearty Soul on MSNNew Ozempic Side Effect Sparks Growing Concern Among UsersHere's the Average Social Security Benefit at Ages 62, 67, and 70 General Mills CEO Harmening: ‘We don’t sell Cheerios in the ...
Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...
9hon MSN
With Britain set to be as hot as Barbados and Malibu in the coming days, medics have warned those taking revolutionary weight ...
Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results